Summary
The effects of simvastatin 40 mg per day for 14 weeks on the pituitary-testis axis of 19 men with familial hypercholesterolaemia have been examined in a single-blind study.
Simvastatin significantly reduced serum low density lipoprotein (LDL) cholesterol and triglycerides by 45% and 30%, respectively, and significantly increased high density lipoprotein (HDL) cholesterol by 15%.
The alterations, which were stable 4 weeks after the start of treatment, were not associated with any significant change in sperm quality, the seminal plasma concentrations of various sex gland products (prostate-specific acid phosphatase, polyamines, citrate, fructose, α-glucosidase), or the serum concentrations of cortisol, testosterone, LH, FSH, or prolactin.
It is concluded that a short-term reduction in circulating LDL-cholesterol has no marked effect on testicular function or sperm quality.
Similar content being viewed by others
References
Alberts AW, Chen J, Kuran G, Hunt V, Huff J, Hoffman C, Rothrock J, Stapley E, Albers-Schonberg G, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J (1980) Mevinolin: a highly potent competitive inhibitor of hydroxy-methylglutaryl-coenzyme A reductase and a cholesterol lowering agent. Proc Natl Acad Sci USA 77: 3957–3961
Bilheimer D, Grundy S, Brown M, Goldstein J (1983) Mevinolin and colestipol stimulate receptor mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci USA 80: 4124–4128
Gwynne JT, Strauss III JF (1982) The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 3: 299–329
Farnsworth WH, Hoeg JM, Maher M, Brittain EH, Sherins RJ, Brewer Jr HB (1987) Testicular function in Type II hyperlipo-proteinemic patients treated with lovastatin (mevolin) or neomycin. J Clin Endocrinol Metab 65: 546–550
Hoffman WF, Alberts AW, Anderson PS, Chen JS, Smith RL, Willard AK (1986) 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Sidechain ester derivatives of mevinolin. J Med Chem 29: 849–852
Slater EE, MacDonald JS (1988) Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. Drugs 36 [Suppl 3]: 72–82
Germershausen JI, Hunt VM, Bostedor RG, Bailey PJ, Karkas JD, Alberts AW (1989) Tissue selectivity of the cholesterol lowering agents lovastatin, simvastatin and provastatin in rats in vivo. Biochem Biophys Res Commun 158: 667–675
Purvis K, Tollefsrud A, Rui H (1989) Correlates of human sperm motility assessed by laser-Doppler spectroscopy. Int J Androl 12: 10–16
Purvis K, Tollefsrud A, Rui H (1989) Stability of sperm characteristics in men with disturbances in sperm quality. Int J Androl 12: 171–178
Rui H, Gerhardt P, Mev»g B, thomassen Y, Purvis K (1984) Seminal plasma characteristics during frequent ejaculation. Int J Androl 7: 119–128
Seiler N, Knödgren B (1978) Determination of di- and polyamines by high performance liquid chromatographic separation of their 5-dimethyl-aminonaphthalene-1-sulphonyl derivatives. J Chromatogr 145: 29–39
Rui H, Thomassen Y, Oldereid NB, Purvis K (1986) Accessory sex gland function in normal young (20–25 years) and middle-aged (50–55 years) men. J Androl 7: 93–99
Chapdelaine P, Tremblay RR, Dube JY (1978) p-Nitrophenyl-a-D-glucopyranoside as substrate for measurement of maltase activity in human semen. Anal Chem 24: 208–211
Lie RF, Schmita JM, Pierre KJ, Gochman N (1976) Cholesterol oxidase based determination by continuous-flow analysis of total and free cholesterol in serum. Clin Chem 22: 1627–1630
Buculo G, David H (1973) Qualitative determination of serum triglycerides by use of enzymes. Clin Chem 19: 476–482
Finley PR, Schifman RB, Williams RJ, Lichti DA (1978) Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. Clin Chem 24: 931–933
Schartz A, Laplanche A, Jouannet P, David G (1979) Within subject variability of human semen in regard to sperm count, volume, total number of spermatozoa and abstinence. J Reprod Fertil 37: 391–395
Overstreet JW (1984) Laboratory tests for human male reproductive risk assessment. Teratogen Carcinogen Mutagen 4: 67–82
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Purvis, K., Tollefsrud, A., Rui, H. et al. Short-term effects of treatment with simvastatin on testicular function in patients with heterozygous familial hypercholesterolaemia. Eur J Clin Pharmacol 42, 61–64 (1992). https://doi.org/10.1007/BF00314921
Issue Date:
DOI: https://doi.org/10.1007/BF00314921